Yangyang Han | Nanomaterials | Research Excellence Award

Prof. Yangyang Han | Nanomaterials | Research Excellence Award

Shandong Second Medical University, China

Prof. Yangyang Han is a distinguished scholar and influential educator whose work spans biochemistry, molecular biology, and biomechanics. He holds a Ph.D. and has built a strong academic foundation that supports his role as a Professor and Master’s Supervisor. Over the years, he has served in several notable capacities, including Associate Professor, Lecturer, and Senior Visiting Scholar at the Institute of Mechanics, Chinese Academy of Sciences, where he deepened his expertise in molecular mechanisms and biomechanical processes. His professional journey includes leadership as Director of the Molecular Biology Teaching and Research Section and service as a Review Expert for the National Natural Science Foundation of China, reflecting his credibility in scientific evaluation and research guidance. As Leader of the Youth Innovation Team of Shandong Provincial Institutions of Higher Education and a Director within the Shandong Society of Biochemistry and Molecular Biology, he continues to foster scientific development and interdisciplinary collaboration. His research interests focus on molecular regulation, cellular biomechanics, and biomedical innovation, contributing to impactful advancements in the field. With recognition for his academic leadership and scientific service, Prof. Han remains committed to driving research excellence, nurturing emerging scholars, and advancing knowledge in life sciences.

Profiles: Scopus | Orcid

Featured Publications

Bai, L., Qian, X., Zhang, H., Yuan, Y., Cui, X., Cheng, M., & Han, Y. (2025). Plectin, a novel regulator in migration, invasion and adhesion of ovarian cancer. Cell & Bioscience. https://doi.org/10.1186/s13578-025-01349-2

Han, Y. (2020). RNA-seq reveals the diverse effects of substrate stiffness on epidermal ovarian cancer cells. Aging. https://doi.org/10.18632/aging.103906

Han, Y. (2020). Elevated microRNA-125b inhibits cytotrophoblast invasion and impairs endothelial cell function in preeclampsia. Cell Death Discovery. https://doi.org/10.1038/s41420-020-0269-0

 

Aléxia Thamara Gasparin | Diagnostic | Research Excellence Award

Mrs. Aléxia Thamara Gasparin | Diagnostic | Research Excellence Award

Hilab | Brazil

Mrs. Aléxia Thamara Gasparin is a dedicated biotechnology and pharmacology professional whose academic and research journey reflects strong commitment to scientific advancement and health innovation. She holds a technical qualification in Biotechnology and Industrial Bioprocesses from SENAI-PR, a Bachelor’s degree in Biological Sciences from the Federal University of Paraná (UFPR), and a Master’s degree in Pharmacology from UFPR. Throughout her education, she developed extensive laboratory expertise, particularly in evaluating the pharmacological potential and adverse effects of bioactive compounds, and she actively participated in specialized training programs in pharmacology, psychopharmacotherapy, epigenetics, and animal handling. Her professional experience includes significant contributions to research projects focused on antinociceptive and anti-inflammatory mechanisms, as well as the development of interactive and didactic scientific materials. She also played a key role in science outreach and health-related extension activities. Currently, she is part of the research and development team at Hilab, where she contributes to the innovation of remotely operated laboratory tests (RTL) and internationally patented products designed to expand access to healthcare technologies in Brazil. Her achievements include top rankings and awards in scientific presentation events, highlighting her proficiency and dedication. Aléxia continues to build a meaningful career focused on pharmacology, biotechnology, and health democratization.

Profile: Scopus

Featured Publication

Pharmacological Interaction Between Cannabidiol and Tramadol on Experimental Diabetic Neuropathic Pain: An Isobolographic Analysis

Author: Cannabis and Cannabinoid Research

Year: 2024